Patent · US Active

Guanidine compounds as anesthetics and for treatment of nervous system disorders

US7868028B2 · kind B2 · utility

2Cited by

1References

1Claims

0Family size

Assignee

Fred Drasner · US

Inventors

Kenneth Drasner · San Francisco, US
Kevin T. Weber · Fremont, US

Key dates

Filing date	Jun 17, 2002
Grant date	Jan 11, 2011
Priority date	—
Expiry date	Oct 29, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel guanidine compounds having the formulain which R1, R2 and R4 are as defined, are effective as sodium channel blockers in neuronal mammalian cells and as anesthetics and/or analgesics, particularly local spinal and/or epidural anesthetics, for alleviation of neuropathic pain, for providing a neuroprotective effect, and for producing anti-convulsant effects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.